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Abstract
Background: Healthcare workers are still recognised as a high-risk group for latent TB infection (LTBI). Therefore, the 
screening of people employed in the healthcare sector for active and LTBI is fundamental to infection control 
programmes in German hospitals. It was the aim of the study to determine the prevalence and putative risk factors of 
LTBI.
Methods: We tested 2028 employees in the healthcare sector with the QuantiFERON-Gold In-tube (QFT-IT) test 
between December 2005 and May 2009, either in the course of contact tracing or in serial testing of TB high-risk 
groups following German OSH legislation.
Results: A positive IGRA was found in 9.9% of the healthcare workers (HCWs). Nurses and physicians showed similar 
prevalence rates (9.7% to 9.6%). Analysed by occupational group, the highest prevalence was found in administration 
staff and ancillary nursing staff (17.4% and 16.7%). None of the individuals in the trainee group showed a positive IGRA 
result. In the different workplaces the observed prevalence was 14.7% in administration, 12.0% in geriatric care, 14.2% 
in technicians (radiology, laboratory and pathology), 6.5% in admission ward staff and 8.3% in the staff of pulmonary/
infectious disease wards. Putative risk factors for LTBI were age (>55 years: OR14.7, 95% CI 5.1-42.1), being foreign-born 
(OR 1.99, 95% CI 1.4-2.8), TB in the individual's own history (OR 4.96, 95% CI 1.99-12.3) and previous positive TST results 
(OR 3.5, 95% CI 2.4-4.98). We observed no statistically significant association with gender, BCG vaccination, workplace 
or profession.
Conclusion: The prevalence of LTBI in low-incidence countries depends on age. We found no positive IGRA results 
among trainees in the healthcare sector. Incidence studies are needed to assess the infection risk. Pre-employment 
screening might be helpful in this endeavour.
Background
The risk of latent tuberculosis infection (LTBI) and active
tuberculosis (TB) as an occupational disease is well estab-
lished and healthcare workers (HCWs) are still recogn-
ised as a high-risk group for LTBI [1-3]. Therefore, the
screening of individuals employed in the healthcare sec-
tor for active TB and LTBI is fundamental to infection
control programmes in hospitals, especially in low-inci-
dence countries like Germany with a TB incidence of 6.1/
100.000 in 2007 [4,5]. In accordance with the German
guidelines of occupational safety and health legislation
(OSH) HCWs are screened routinely depending on risk
assessment. All HCWs working in pulmonary wards and
labs (contact with contagious TB-material or TB cases)
are screened every year. All other HCWs are routinely
screened every third year. After exposure to a TB index
case all close contacts were examined within the scope of
contact investigation [6]. In accordance with the national
guideline the Interferon-gamma release assay (IGRA) is
used for the screening procedures. Early detection and
treatment of LTBI are also recommended to prevent pro-
gression from latent TB infection to active TB [7].
So far, surveillance for LTBI in high-risk groups such as
healthcare workers has been hampered by the non-speci-
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ficity of the tuberculin skin test (TST) in Bacillus
Calmette-Guérin (BCG) -vaccinated individuals. How-
ever, there is no gold standard test for LTBI. For about a
century the tuberculin skin test (TST) was the only avail-
able test for the detection of LTBI. But the TST has its
limitations, including cross-reactivity to PPD (BCG-vac-
cination strain) and several non-tubercular mycobacteria
(NTM) infections and the need for a second visit, which
often results in missed follow-ups [8].
These limitations of the TST were overcome by the
development of the new T-cell based in-vitro Interferon-
γ release assays (IGRAs), which use M. tuberculosis-spe-
cific antigens [3,9,10]. These assays, commercially avail-
able in the form of QuantiFERON- TB and T -SPOT . TB,
have been approved by the US Food and Drug Adminis-
tration and endorsed in major national guidelines for use
instead of or in addition to the TST for LTBI screening
[4,7,11,12]. The third generation of the QuantiFERON
test (QuantiFERON®TB Gold In-Tube, QFT-IT) measures
in-vitro IFN-γ production by T-cells during in-vitro stim-
ulation with peptides of the M. tuberculosis-specific anti-
gens of the region of difference (RD-1) ESAT-6, CFP-10
and TB7.7. These antigens are not shared by any of the
BCG vaccine strains nor by the more common species of
NTM (e.g. M. avium) [13,14]. Available evidence
reviewed elsewhere [3,13,15] suggests that these IGRAs
have higher specificity and at least an equal level of sensi-
tivity as the TST and are unaffected by previous BCG
vaccination and most NTM. Therefore this test reduce
the risk of these tests overestimation due to cross-reac-
tions with BCG vaccination or exposure to environmen-
tal mycobacteria [15].
So far, several systematic investigations of LTBI in
HCWs using TST and IGRA have been published [16-
18], showing a high proportion of TST-positive/IGRA-
negative results, which is most likely explained by BCG
vaccination. A couple of studies had estimated the preva-
lence of LTBI in HCWs in low-incidence countries with
the new in-vitro tests [15,18-26]. These prevalence rates
are much lower than those assumed for German HCWs
so far. The observed previous prevalence rate in German
HCWs with the non-specific TST was 24% [27].
It was the aim of our study to describe the prevalence in
employees in the healthcare sector and the putative risk
factors for LTBI.
Methods
Study design and setting
A cross-sectional study was conducted in 14 different
kinds of hospitals in Germany. One of the clinics is a spe-
cialist lung disease clinic and the other clinics are general
h o s p i t a l s .  S o m e  o f  t h e m  a l s o  h a v e  s p e c i a l  i n f e c t i o n
wards. The study population consisted of people
employed in the healthcare sector tested between
December 2005 and May 2009, either in the course of a
contact tracing or in serial testing of TB high-risk groups
in accordance with German occupational safety and
health legislation (OSH) by occupational physicians. A
total of 2028 employees in the healthcare sector were
enrolled in the study. Of these, two smaller subgroups
were already described in two studies by Nienhaus et al.
(n = 261) [26] and Schablon et al. (n = 270) [24]. There
were no exclusion criteria for study participants. The par-
ticipants who had previous TB history were not excluded.
The small sample size of 1.2% of participants with previ-
ous TB history did not affect the prevalence of LBTI in
this study population:
The study protocol was approved by the ethics commit-
tee of the Hamburg Medical Council. All individuals gave
their written informed consent prior to their inclusion in
the study.
Diagnostic methods
For the IGRA, the QuantiFERON-TB Gold In-Tube test
was used (Cellestis Limited, Carnegie, Australia). This
whole-blood assay uses overlapping peptides correspond-
ing to ESAT-6, CFP-10 and a portion of tuberculosis anti-
gen TB7.7 (Rv2654). Stimulation of the antigenic mixture
occurs within the tube used to collect the blood. Tubes
were incubated at 37°C overnight before centrifugation,
and INF-γ release was measured by ELISA in accordance
with the manufacturer's protocol. The QFT-IT was per-
formed according to the manufacturer's instructions
which consider a result to be positive if the IFN-γ
response of TB antigen minus Nil was ≥ 0.35 UI/ml. The
BCG vaccination status was confirmed by medical
records or the presence of vaccination scars.
For the TST the intradermal Mendel-Mantoux test
(two tuberculin units, 0.1 ml purified derivate (PPD) RT
23, Staten Serum Institute, Copenhagen, Denmark) was
used. Older TST results were conducted with the multi-
puncture test (GT 10, Behring Tuberculin). A TST with
indurations >5 mm was considered positive according to
the German national guidelines [28].
Questionnaire items
Information on the following variables was collected
using a standardised questionnaire: age, gender, reason
for testing, occupational exposure to TB, time of occupa-
tion in the healthcare sector, family history of TB, place of
birth, prior TST, job title, workplace, chest radiographic
findings and BCG vaccination. BCG vaccination was
assessed through the individual vaccination register or
based on scars.
All participants with a positive QFT-IT were offered a
clinical and radiological examination to rule out active
TB. Treatment of LTBI with isoniazid for 9 months was
proposed in accordance with the German recommenda-
tions.Schablon et al. BMC Infectious Diseases 2010, 10:107
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Statistical analysis
Data analysis was performed using SPSS, Version 14
(SPSS Inc., Chicago, Illinois). Chi-square tests were used
for categorical data. Adjusted odds ratios (OR) and 95%
confidence intervals (CI) for QFT-IT, depending on dif-
ferent putative predictive variables, were calculated using
conditional logistic regression. Model-building was per-
formed backwards, using the chance criteria for variable
selection [29]. There was a strong correlation between
age and duration of employment. Therefore, we refrained
from analysing both variables simultaneously.
Results
Study population
The study population comprises 2028 HCWs. 24 HCWs
(1.2%) were excluded from the analysis due to indetermi-
nate QFT-IT results. The majority of the participating
HCWs (77.2%) were female and the mean age was 38.6
years (SD ± 11.5). A history of BCG vaccination was
recorded for 45.2% of the participants. 16.8% of the study
population were born outside Germany or had a history
of migration (Table 1). Most of the foreign-born partici-
pants came from former Soviet Union (NIS) states and
Eastern Europe (12.5%), 1.5% came from Western Euro-
pean countries like Spain, France, Sweden, Portugal or
Switzerland. 1.3% were born in Asia, e.g. the Philippines,
Thailand or India, and 1.0% of the participants immi-
grated from Africa or South America (no table). In the
subgroup of participants from the former Soviet Union/
Eastern Europe, a positive IGRA was observed in 15.9%
(40/251), in the subgroup born in Western Europe the
prevalence of a positive IGRA was 26.7% (8/30) and the
highest prevalence of 37% was found in the subgroup
born in Asia (10/27) (no Table). However, the differences
were not statistically significant.
54.2% of the total study population were nurses, 14.0%
were physicians, and 5.5% were trainees or young profes-
sionals (physicians, medical staff, nurses, therapists).
3.5% were laboratory staff, a total of 4.6% were adminis-
tration staff (including kitchen staff, secretaries, building
services), 3.9% were cleaning staff and 5.1% of the partici-
pants worked as social workers and auxiliaries (including
medical secretaries, volunteers) (Table 1).
Within the scope of serial examinations of high-risk
groups 68.7% (n = 1376) of HCWs were screened and 137
(10.0%) of these participants were positive in the QFT-IT
(Table 1). 628 employees (31.3%) were screened in the
course of contact tracing after exposure to a TB index
case; in this group 9.7% were QFT-IT positive (no table).
We did not find any active TB cases.
A positive QFT-IT result was observed in 198 (9.9%)
participants and 480 (24.0%) participants reported a posi-
tive TST (Table 1). Of the 480 participants with a positive
previous TST, 94 (19.6%) were confirmed by the IGRA
Previous TST results were mostly estimated with the old
multipuncture test (n = 352). Out of 507 participants with
no TST in their medical history, 48 persons (9.5%) were
positive by QFT-IT (Figure 1).
The prevalence of LTBI correlated with age. In the sub-
group with participants under 25 years, LTBI prevalence
was 1.6% and increased to 25.0% in the subgroup with
participants over 55 years.
Profession
Regarding the prevalence of LTBI in different professions
we found rates of 9.7% and 9.6% in nurses and physicians.
None of the individuals in the trainee group showed a
positive IGRA result. The highest prevalence was
observed in the group of administration staff and ancil-
lary nursing staff (including endoscopy and bronchos-
copy staff and surgery staff) (17.4% to 16.7%). In the
known risk groups of technicians including radiology and
laboratory staff, the observed prevalence varied from
3.6% to 11.4%. The observed prevalence in the group of
cleaning staff was 11.4%. All IGRA-positive participants
in this group have had a history of migration (no table).
Workplace
The observed prevalence in the admission ward was 6.5%,
compared to 8.3% in pulmonary/infectious disease wards.
The highest prevalence was observed in administration
staff (14.7%), geriatric care staff (12.0%) and technicians
including radiology, laboratory and pathology staff
(14.2%). However, the differences were not statistically
significant.
Duration of employment in healthcare sector
The prevalence of LTBI increased with the duration of
employment, from 5.4% in the group with less than 5
years of employment up to 12.7% in the subgroup with
more than 20 years in the healthcare sector. However, the
correlation between duration of employment and age was
high (r = 0.665**).
Putative risk factors
Putative risk factors for a positive IGRA result were age
(>55 years: OR14.7, 95% CI 5.1-42.1), being foreign-born
(OR 1.99, 95% CI 1.4-2.8) and TB in the individual's own
history (OR 4.96, 95% CI 1.99-12.3). Using the subgroup
with a negative TST in their history as comparison group,
the OR for those with no previous TST in their medical
history was elevated (1.7, 95% CI 1.1-2.5). For those with
previous positive TST results the OR was 3.5 (95% CI 2.4-
4.98). No statistically significant association was observed
for gender, BCG vaccination, workplace and profession
(Table 2).
Thus, so far no active TB has been diagnosed in any of
the healthcare employees who had a positive QFT result
during the study period.Schablon et al. BMC Infectious Diseases 2010, 10:107
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Table 1: Description of study population
Variable N = 2004 %
Age (years)
> 25 253 12.6
25-35 years 481 24.0
35-45 years 571 28.5
45-55 years 507 25.3
> 55 years 192 9.6
Gender
Female 1548 77.2
Male 456 22.8
Country of birth
Germany 1667 83.2
Foreign-born 337 16.8
TB in own history
Yes 24 1.2
No 1980 98.8
BCG vaccination
Yes 905 45.2
No 1099 54.8
Profession
Nurse 1087 54.2
Physician 281 14.0
Trainee 110 5.5
Therapist 66 3.3
Discussion
To the best of our knowledge, our study is the largest
study to investigate the performance of the QFT-IT when
screening healthcare staff in low-incidence countries like
Germany. In this study we determined a low prevalence
of positive QFT-IT results of 9.9%. This prevalence was
substantially lower compared to the findings assumed in
the past with the TST (24%)[27]. HCW with appositive
TST were more often BCG vaccinated than those with a
negative TST (66.2% versus 39.2%). Therefore the dis-
crepancy is most likely due to the BCG-vaccination.
In a further analysis of smaller subgroups of our study
population, Nienhaus et al. investigated 261 HCWs from
different types of hospitals who are routinely screened for
TB as stipulated by German OSH legislation using the
QFT-IT and TST with a cut-off >5 mm. The prevalence
of positive QFT-results was 9.6% [26]. Schablon et al.
investigated the prevalence of LTBI in a hospital for pul-
monary diseases (in the northern part of Germany) which
was also included in our study population. They found a
p r e v a l e n c e  o f  p o s i t i v e  Q F T - I T  i n  7 . 2 %  o f  t h e  p a r t i c i -
pants[24].
In line with this, Ringshausen and colleagues reported
in another study a prevalence of LTBI of 9.1% among
healthcare workers during a contact investigation in a
hospital after close contact with a smear-negative index
case [23]. In addition, Stebler et al. [22] investigated the
prevalence of LTBI among employees at the hospital of
Berne using the IGRA. A positive IGRA was carried out
for 59/777 HCWs (7.6%). A recent Australian study found
comparable results for the frequency of positive QFT-IT
(6.7%) [18]. Harada et al. also observed the performance
of the QFT-G for LTBI detection by testing 332 HCWs in
a Japanese general hospital and found a prevalence of
positive QFT-G of 9.9% [20].
In contrast to these findings, in the study among 95
HCWs working in departments of radiology, Barsegian et
al. observed a prevalence of LTBI of 1% using the T-SPOT
[21]. Also, Soborg and colleagues [19] investigated the
prevalence at two departments of infectious diseases in
Copenhagen using QFT- TB in 139 HCWs. 34 HCWs
were office staff without routine patient contact and 105
HCWs had direct patient exposure. The observed preva-
lence in this study population was also 1% compared to
34% with TST with a cut-off >12 mm. The positive QFT-
TB rate was much lower than the estimated prevalence in
our study.
In a French study Tripodi and colleagues [30] compared
the performance of the TST and IGRA in French HCWs
when using a high cut-off for the TST (>10 mm). 18.9% of
the HCWs with recent contact to an acid-fast bacillus
(AFB) -positive TB case were positive in the QFT . The
rate of positive QFT is lower than the one observed in
Portuguese HCWs (32.6%) [31] but higher than the oneSchablon et al. BMC Infectious Diseases 2010, 10:107
http://www.biomedcentral.com/1471-2334/10/107
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(10%) observed in German HCWs [23,24,26], which cor-
responded with a higher TB incidence in the Portuguese
general population.
In our study none of the individuals in the trainee
group showed a positive IGRA result. This finding sug-
gests that LTBI risk is very low at the beginning of the
training period in the various occupations (nurses, medi-
cal students, physical therapists). Similar to our findings,
Chee et al. examined 270 medical students in Singapore
in their final year of study. A positive T-Spot was found in
4.3% of the students. But this study was carried out in a
country with intermediate tuberculosis incidence and it
determined the prevalence at the end of training [32].
Therefore, the prevalence is somewhat higher than in
Germany.
Another aim of our study was to determine putative
risk factors for LTBI. We found that LTBI was associated
with age (<25 years 1.6%, >55 years 25%), foreign birth
and previous positive TST or no previous TST. The
higher prevalence in older HCW s was also observed in
other studies [20,26,33,34] and might be due to a cohort
effect or the longer time at risk. These findings suggest
that the IGRA describes the age dependency of LTBI
prevalence in the German population very well. The asso-
ciation between foreign birth and LTBI was also observed
on earlier analysis of a smaller subgroup of our study pop-
ulation published by Nienhaus et al. [26], but due to the
smaller sample size the risk was not statistically signifi-
cant.
We found no association between a positive QFT-IT
and different kinds of occupations and workplaces. Rota-
tion of the staff is an explanation for the lack of any asso-
ciation. We do not know how long the individuals were
employed in a specific work area. In the course of their
career, physicians and nursing staff work in various wards
and hospitals; this makes it hard to attribute a positive
test result to a specific work area. Furthermore, our
cross-sectional design might dilute the expected associa-
tion. We found no explanation for the high rate of posi-
tive QFT-IT results in the subgroup of the administration
staff. We examined potential risk factors, e.g. age, migra-
tion, reason for testing (contact investigation), but no
association for these putative risk factors was found. It
should also be born in mind that our data are derived
from routine screening of exposed HCWs. Therefore,
even the seemingly unexposed group "administration" is
not really unexposed.
Torres et al. investigated Portuguese HCWs with the
TST and QFT-IT, and obtained findings similar to ours.
Surprisingly, neither risk assessment (workplace) nor
profession was associated with a positive TST or IGRA
[31].
In contrast to our results, three biological studies
showed a job-related exposure to TB for employees in the
healthcare sector. Firstly, a molecular biological finger-
print study in Germany observed that the risk of active
TB for HCWs is not higher compared to the general pop-
ulation. However, when the disease occurred, TB infec-
tion is most probably due to occupational exposure. In 8/
10 HCWs who developed TB the infection was a conse-
quence of occupational exposure. Secondly, Ong et al.
found genotyping or epidemiological evidence of job-
Administration 92 4.6
Ancillary nursing staff 30 1.5
Cleaning staff 79 3.9
Social workers/auxiliary 102 5.1
Radiology staff 28 1.4
Laboratory staff 70 3.5
Other 59 2.9
Workplace
Admission ward 138 6.9
Infection ward 303 15.1
Geriatric care 309 15.4
Radiology/Laboratory/
Pathology
176 8.8
Administration 75 3.7
Intensive care 213 10.6
Clinic ward 721 36.0
Other 69 3.4
History of TST
Negative TST in history 1017 50.7
Positive TST in history 480 24.0
No TST 507 25.3
Table 1: Description of study population (Continued)Schablon et al. BMC Infectious Diseases 2010, 10:107
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related transmission in at least 32% of HCWs [35]. And
thirdly, de Vries and colleagues determined which TB
cases among HCWs were caused by infections acquired
at the workplace. Of a total of 101 TB cases, the infection
pathways of 67 cases could be established; 42% were due
to infection at work [36]. The majority of work-related
active TB cases occurred when the infection risk was not
suspected and preventive measures were not taken.
In a recent review occupational risk factors were linked
to working in internal or respiratory medicine wards,
duration of employment in the healthcare sector and TB
exposure [3]. So far, the occupational risk of LTBI of dif-
ferent occupations has been investigated in several con-
ventional studies. Most of these studies showed a
significant increase of >2 in the relative risk for nurses.
Several studies of varying quality examined the infection
risk for physicians. Because of the inadequate data it is
difficult to evaluate the LTBI risk in different medical
specialties; the results do not indicate an increased infec-
tion risk for physicians. Only pathologists bear an
increased LTBI risk [1].
Figure 1 Description of the study population depending on TST and IGRA.Schablon et al. BMC Infectious Diseases 2010, 10:107
http://www.biomedcentral.com/1471-2334/10/107
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Table 2: Frequency and adjusted odds ratios (OR) and 95% confidence intervals (95% CI) for covariates associated with 
QFT-IT results
Covariates QFT-IT
Negative n/%
QFT-IT
Positive n/%
Odds Ratio 95% CI
Age **
> 25 years 249 (98.4) 4 (1.6) 1
25-35 years 449 (93.3) 32 (6.7) 3.8 1.3-11.2
35-45 years 524 (91.8) 47 (8.2) 4.4 1.6-12.5
45-55 years 440 (86.8) 67 (13.2) 7.6 2.7-21.4
> 55 years 144 (75.0) 48 (25.0) 15.1 5.3-43.4
Gender**
Female 1392 (89.9) 156 (10.1) 1
Male 414 (90.8) 42 (9.2) 1.2 0.8-1.7
Country of birth**
Germany 1529 (91.7) 138 (8.3) 1
Foreign-born 277 (82.2) 60 (17.8) 2.0 1.4-2.8
TB in own history**
No 1792 (90.5) 188 (9.5) 1
Yes 14 (58.3) 10 (41.7) 4.9 1.97-12.2
BCG vaccination
No 995 (90.5) 104 (9.5) 1
Yes 811 (89.6) 94 (10.4) 0.9 0.7-1.3
Profession
Physicians 254 (90.4) 27 (9.6) 1
Nurses 982 (90.3) 105 (9.7) 0.94 0.6-1.6
Administration staff 146 (85.4) 25 (14.6) 1.1. 0.5-2.2Schablon et al. BMC Infectious Diseases 2010, 10:107
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In addition, two recently published incidence studies of
Italian and Thai HCWs detected a higher risk of LTBI for
specific occupational groups and units. One was a study
with a homogeneous population of healthcare workers in
a low-incidence area in Italy. Franchi and colleagues [37]
found a low prevalence rate (6%). Working in microbiol-
ogy (OR 4.16, 95% CI 1.27-13.6), dialysis/nephrology (OR
2.52, 95% CI 1.36-4.65), gynaecology/obstetrics (OR 2.46,
95% CI 1.24-4.86) and age >47 years (OR 1.98, 95% CI
1.14-3.46) were significant predictors for TB infection
[30]. The second study investigated the association of
workplace and the recent onset of L TBI in HCW s in a
university hospital in Thailand. Working at in- and out-
patient units and a history of tuberculosis exposure in the
past year were significant predictors for tuberculin con-
version [38]. However, these two studies were hampered
by using the TST for LTBI diagnosis.
Another Italian study observed the prevalence among
115 HCWs tested simultaneously with both the TST and
the IGRA. Overall, 53% of the individuals were TST-posi-
tive, 36.5% according to T-SPOT.TB and 25.2% according
to QFT. An association between positives test results and
an increased occupational risk of exposure to Mycobacte-
rium tuberculosis was observed. Nurses and nurse assis-
tants were more likely to be QFT-positive than physicians
[39]. Demkow and colleagues found a higher risk of
acquiring LTBI for TB lab workers (50%) and TB ward
staff (34%) [40]. In our study the prevalence of LTBI in lab
workers was lower (11.4%), but we could not distinguish
between TB lab and non-TB lab.
Technicians and special ward staff 175 (90.2) 19 (9.8) 0.7 0.3-1.5-
Unknown 51 (86.4) 8 (9.9) 1.3 0.5-3.3
Social workers/auxiliaries 198 (93.4) 14 (6.6) 0.8 0.4-1.8
Workplace
Other clinic ward 653 (90.6) 68 (9.4) 1
Unknown 64 (92.8) 5 (7.2) 0.9 0.3-2.4
Admission ward 129 (93.5) 9 (6.5) 0.7 0.2-2.3
Infection ward 278 (91.7) 25 (8.3) 1.3 0.4-3.8
Geriatric care 272 (88.0) 37 (12.0) 1.7 0.6-4.9
Technicians 151 (85.8) 25 (14.2) 2 0.6-6.4
Administration 64 (85.3) 11 (14.7) 1.7 0.5-5.7
Intensive care/surgery room 195 (91.5) 18 (8.5) 1.1 0.9-3.3
Previous TST in medical history**
Negative TST 961 (94.5) 56 (5.5) 1
Positive TST 386 (80.4) 94 (19.6) 3.5 2.4-4.99
No TST 459 (90.5) 48 (9.5) 1.7 1.1-2.5
** The final multivariate logistics model includes the variables age, gender, TST in own history, TST history and country of birth.
Table 2: Frequency and adjusted odds ratios (OR) and 95% confidence intervals (95% CI) for covariates associated with 
QFT-IT results (Continued)Schablon et al. BMC Infectious Diseases 2010, 10:107
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In Germany all HCWs with a positive TST obtained
chest x-rays after contact with a TB-index case or other-
wise every third year. After the introduction of the IGRA
o n l y  H CW s  w i t h  a  po s i t i v e  I G RA  o b t a i n  c h e s t  x - r a y s.
Therefore, introducing IGRA for TB screening in Ger-
many reduces the number of X-rays and the amount of
preventive chemotherapy needed by a high percentage
(from 24% to 9.9%) without missing an active case of TB.
Despite our increasing knowledge, several key ques-
tions about latent TB infection remain unanswered. Par-
ticularly, it should be noted that TST and IGRA identify
an adaptive immune response against M. tuberculosis,
but not necessarily a latent infection. A positive result of
the diagnostic tests is primarily a measure of an immuno-
logical response to stimulation by mycobacterial antigens
that should not therefore be equated with the presence of
live M. tuberculosis in the human host. It is also uncertain
how long adaptive immune response towards mycobacte-
rial antigens persist in the absence of live mycobacteria.
For these reasons, according to the recently published
TBNET consensus statement regarding latent TB the
term "latent infection" would at best implicate "lasting
tuberculosis immune response" [41].
Limitation
The main limitation of our study is the cross-sectional
study design, as mentioned before. Because of this,
changes over time cannot be taken into consideration.
We could not discriminate between recent and old infec-
tions. Therefore, in spite of the big sample size of more
than 2000 participants, no statement can be made regard-
ing the risks at different kinds of workplaces and occupa-
tions in the healthcare sector.
Conclusion
In summary, our data corroborates the results of previous
studies that the prevalence of LTBI in low-incidence
countries depends on age. One important result of our
study is that we found no positive IGRA results among
trainees in the healthcare sector. Introducing IGRA for
TB screening in Germany reduced the number of X-rays
and the preventive chemotherapy by a high percentage
(from 24% to 9.9%) while no active TB case was missed.
Serial examinations are required in order to identify dif-
ferent kinds of occupations or workplaces especially at
risk of LTBI.
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